Browse Articles

Discover research articles across all indexed journals

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer

Nature Toni K. Choueiri, Jamie Merchan, Amita Patnaik et al. Jul 01, 2026 DOI: 10.1038/s41586-026-10718-x

Abstract Clear cell renal cell carcinoma (ccRCC) is largely driven by the transcription factor hypoxia-inducible factor 2α (HIF-2α) 1 . Here we show that monotherapy with casdatifan—an orally bioavailable, potent and selective HIF-2α inhibitor 2 —produces meaningful, durable antitumour activity with manageable safety in individuals with refractory metastatic ccRCC. Dose-expansion data from the ARC-20 study ( NCT05536141 ) are presented, including for the 100 mg once daily (QD) cohort ( n  = 32) and the total cohort ( n  = 127). Treatment discontinuation from casdatifan-related adverse events was infrequent (3%), and class-effect toxicities included anaemia and hypoxia. The confirmed objective response rates (ORRs) were 35% (95% confidence intervals (CI) = 19–55%; 100 mg QD) and 31% (95% CI = 23–40%; total); median progression-free survival (PFS) was not estimable (95% CI = 5.7–not estimable; 100 mg QD) and 12.2 months (9.4–20.6; total). Greater maximal reductions in serum erythropoietin were associated with improved clinical outcomes, including a higher ORR ( P  = 0.001), lower rates of progressive disease ( P  = 0.003) and longer PFS ( P  = 0.006). Erythropoietin expression was restricted to cancer cells and was significantly higher at the mRNA level in patients with clinical benefit. Concordantly, HIF-2α protein expression and HIF-2α expression signature were associated with prolonged PFS. Overall, our findings show that casdatifan achieves meaningful, durable responses with manageable safety. These data establish a link between on-target HIF-2α pathway modulation, tumour biology and clinical efficacy.

Linker‐Engineered Dimeric Acceptors Afford Efficient Organic Photocatalytic Hydrogen Evolution via Tailored Nanomorphology for Long‐Lived Charge Accumulation

Advanced Materials Jin‐Woo Lee, Cheng Sun, Yang Song et al. Jul 01, 2026 DOI: 10.1002/adma.73648

ABSTRACT Organic bulk‐heterojunction (BHJ) nanoparticles are promising candidates for solar‐to‐hydrogen conversion. While the development of organic photocatalysts (OPCs) has leveraged advances in organic photovoltaics (OPVs), molecular design rules tailored to photocatalysis remain underdeveloped. Here we introduce linker‐engineered dimeric acceptors that tune self‐assembly and thereby control BHJ nanoparticle morphology, enabling high‐performance OPCs. Two dimer acceptors, DY1 (unfused linker) and DY2 (fused linker), are synthesised from a monomer analogue (MY), establishing a self‐assembly trend of MY > DY2 > DY1. The stronger intermolecular assembly of MY is consistent with a quasi‐core–shell morphology that reduces catalytically accessible donor–acceptor interfaces, whereas the weaker intermolecular assembly of DY1 is associated with a more intermixed morphology and increased recombination losses. In contrast, DY2 exhibits a morphology consistent with improved pathway continuity and sufficient donor/acceptor exposure at the particle surface, supporting enhanced accumulation of long‐lived, surface‐stabilised charges. Consequently, PM6:DY2 OPCs deliver a hydrogen evolution rate of 25.3 µmol h −1 cm −2 , outperforming PM6:MY (1.9 µmol h −1 cm −2 ) and PM6:DY1 (11.9 µmol h −1 cm −2 ). Notably, this performance trend contrasts with that of the corresponding OPVs, suggesting that photovoltaic design principles do not necessarily translate directly to photocatalysts.

Artificial Topological Nanostructures: Strategies for Design, Manufacturing, and Biomedical Applications

Advanced Materials Jianli Zuo, Yijie Wu, Yuhan Dong et al. Jul 01, 2026 DOI: 10.1002/adma.73542

ABSTRACT The rational design of nanoscale architectures with well‐defined and nontrivial topologies has emerged as an important direction in materials science for regulating structure‐dependent physicochemical and biological functions. However, a focused framework centered on artificial topological nanostructures (ATNs) remains underdeveloped. In this review, we focus on ATNs, a class of engineered nanosystems in which global connectivity and deformation‐invariant topology serve as design parameters beyond composition and morphology. Compared with conventional nanostructured materials, ATNs represent a topology‐driven design paradigm enabling controllable structural organization at the nanoscale. We summarize recent progress in ATNs featuring representative motifs such as Möbius strips, trefoil knots, and interlocked rings, highlighting how topology governs structural stability and function. Emphasis is placed on topology as the central organizing principle of structure‐function relationships in ATNs. Key design principles and assembly strategies are discussed across reticular frameworks, peptide and nucleic acid‐based systems, and soft‐matter assemblies, focusing on programmable encoding of topological states. We further highlight fabrication strategies and emerging biomedical applications in nanomedicine, where topology‐dependent properties enhance performance. Finally, we outline key challenges in scalable synthesis, quantitative topology function relationships, and biological translation, and discuss future opportunities for establishing topology as a unifying design paradigm for functional nanomaterials.

TGF-β2 drives lipid droplet accumulation in chondrocytes through the TβRI/p-Smad3/Fabp5 axis

Journal of Biological Chemistry Jieya Wei, Caixia Pi, Yu Qi et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113317

Clinical and radiologic outcomes of immune checkpoint inhibitor therapy in cancer patients with pre-existing interstitial lung disease: A retrospective study from Vietnam.

Journal of Clinical Oncology Thao Ninh Thi Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.343

343 Background: Patients with pre-existing interstitial lung disease (ILD) are frequently excluded from immune checkpoint inhibitor (ICI) clinical trials because of concerns regarding pulmonary toxicity. As a result, real-world data describing outcomes of ICI therapy in this population remain limited. We evaluated clinical and radiologic outcomes of cancer patients with underlying ILD treated with ICIs in routine practice in Vietnam. Methods: This retrospective cohort study included adult cancer patients with radiologic evidence of pre-existing ILD on baseline chest computed tomography who received ICIs for oncologic indications at a tertiary cancer center. Patients with ILD related to prior thoracic radiotherapy were excluded. Clinical data and serial chest CT scans were reviewed over a 12-month follow-up period. Outcomes included overall survival, respiratory-related hospitalizations, immune-related pneumonitis, and radiologic ILD progression. Results: A total of 47 patients were included. Lung cancer was the most common primary malignancy (66.0%). ICIs administered included pembrolizumab (59.6%) and atezolizumab (40.4%), and 59.6% of patients received immunotherapy for at least 6 months. At 12 months, 19 patients (40.5%) were alive, 26 (55.3%) had died, and 2 (4.2%) were lost to follow-up. Among deaths, 65.4% were attributed to malignancy-related causes, while 11.5% were associated with ILD progression. Respiratory-related hospitalizations occurred in 8.5% of patients, and ICI-associated pneumonitis was observed in 10.6%. Radiologic assessment demonstrated stable or improved ILD in 76.6% of patients, whereas 23.4% showed radiologic progression. Conclusions: In this real-world cohort of cancer patients with pre-existing ILD, mortality was predominantly driven by progression of the underlying malignancy rather than ILD-related complications. Although immune-related pulmonary events occurred in a subset of patients, most demonstrated radiologic stability over time. These findings support further prospective studies to better define pulmonary risk stratification in this underrepresented population. Clinical and radiologic outcomes at 12-month follow-up (N = 47). Outcome Patients, n (%) Vital status at 12 months Alive 19 (40.5) Deceased 26 (55.3) Lost to follow-up 2 (4.2) Cause of death* Malignancy-related 17 (65.4) ILD progression 3 (11.5) Other non-cancer causes 6 (23.1) Respiratory complications Hospitalization for ILD 4 (8.5) ICI-associated pneumonitis 5 (10.6) Radiologic ILD changes on CT Stable or improved 36 (76.6) Progressed 11 (23.4) *Percentages for causes of death are calculated among deceased patients.

AI as a clinical teaching co-pilot: A real-world evaluation of an LLM-integrated bedside microteaching model in inpatient oncology.

Journal of Clinical Oncology Mathew George Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.5

5 Background: Structured bedside teaching in inpatient oncology is increasingly displaced by service pressures, particularly in regional centres. Generative AI and large language models (LLMs) such as ChatGPT represent an emerging but underexplored tool for augmenting oncology workforce training, clinical reasoning, and empathetic communication core competencies directly linked to patient outcomes. We evaluated the feasibility, educational impact, and AI performance of Smart Rounds 2.0, a structured LLM integrated bedside microteaching model deployed in a real-world regional oncology unit. Methods: Over eight weeks, structured 20-minute microteaching sessions were embedded into weekday inpatient oncology ward rounds at a regional Australian cancer centre. Twenty-five participants 10 Year 4–5 medical students, 9 resident medical officers, and 6 basic physician trainees completed the programme. Sessions followed a four-step AI-integrated format: LLM generated pre-session MCQs; AI-generated clinical scenarios; senior oncologist-led group discussion; and post-session reflection with repeat MCQs. Clinical clerking competency was assessed using the FAST-ONC mnemonic with de-identified fictional cases. Parallel AI-generated clerking was independently evaluated for clinical completeness, specificity, and detection of psychosocial and empathy cues. Results: All sessions were delivered as scheduled with zero workflow disruption. Post-session MCQ scores improved by a mean of 21%. Participant survey data showed 95% rated sessions as clinically relevant and well-structured; 88% reported improved confidence in oncology clinical reasoning and patient interaction; and 92% supported routine programme integration. LLM clerking achieved 95.5% diagnostic accuracy and demonstrated superior consistency in detecting subtle psychosocial and empathetic language cues compared to human assessors, enabling richer reflective feedback. Key themes from participant feedback included scenario authenticity, group engagement, time-efficiency, and adaptability to learner level. Conclusions: Smart Rounds 2.0 demonstrates that LLMs can be safely and meaningfully embedded into real-world oncology clinical training without disrupting workflow. AI-assisted language analysis offers a novel, scalable mechanism to improve empathy training a domain critical to oncology patient care. This model represents a replicable, low cost framework with direct implications for oncology workforce development across the Asia/Pacific region, where regional training gaps remain a significant challenge.

Voltage imaging of CA1 pyramidal cells and SST+ interneurons reveals stability and plasticity mechanisms of spatial firing

Nature Communications Rotem Kipper, Yaniv Melamed, Qixin Yang et al. Jul 01, 2026 DOI: 10.1038/s41467-026-74834-y

A ROS-Responsive DNA Nanodevice for Targeted Cytosolic siRNA Delivery in Metabolic Dysfunction-Associated Steatohepatitis

Journal of the American Chemical Society Qi Wang, Beibei Zhang, Yuang Wang et al. Jul 01, 2026 DOI: 10.1021/jacs.6c09111

Short- and long-term scaling behavior of blood pressure and pulse arrival time during sleep in healthy controls and patients with obstructive sleep apnea

PLoS ONE Karsten Berg, Jan W. Kantelhardt, Martin Glos et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0339755

Obstructive sleep apnea (OSA) is characterized by recurrent respiratory events that trigger autonomic arousals and blood pressure (BP) surges, contributing to elevated cardiovascular risk. Photoplethysmography (PPG)-derived timing markers such as pulse arrival time (PAT) are frequently used as noninvasive surrogates of BP dynamics, yet their interpretation is confounded by the pre-ejection period and peripheral vascular effects. Here, we used detrended fluctuation analysis (DFA) to quantify short- and long-term scaling exponents of continuous blood pressure (Portapres), PPG-, and PAT-derived signals across sleep stages in healthy individuals and patients with OSA. Directly measured systolic and diastolic BP exhibited a robust short- to long-term crossover across all sleep stages, with elevated short-range exponents ( α 1 > 1 ) and lower long-range exponents ( α 2 < 1 ), reflecting well-organized autonomic and vascular control. In OSA, this crossover persisted but was visibly attenuated, consistent with reduced short-term adaptability of cardiovascular regulation. In contrast, PAT-based indices showed substantially weaker short-range correlations and minimal crossover structure. Systolic PAT displayed almost no separation between α 1 and α 2 , and PPG-derived measures exhibited scaling patterns that differed fundamentally from BP. Across modalities, PAT (whether derived from BP or PPG) failed to reproduce the multiscale organization characteristic of beat-to-beat BP dynamics. Group comparisons further identified systolic BP scaling, particularly the short-range exponent α 1 , as the most sensitive marker of cardiovascular dysregulation in OSA, whereas PAT and PPG provided complementary but physiologically distinct information related to peripheral vascular and autonomic modulation. These findings demonstrate that PAT and PPG timing measures should not be used as surrogates for BP in fractal or scaling analyses and underscore the unique diagnostic value of BP-derived scaling behavior for assessing cardiovascular regulation during sleep.

Electro–thermal benchmarking of low-order lithium-ion battery equivalent circuit models under constant-current and dynamic loading

Scientific Reports Smaranika Mishra, Sarat Chandra Swain, Zefree Lazarus Mayaluri et al. Jul 01, 2026 DOI: 10.1038/s41598-026-44025-2

Urokodia sheds light on the origin of chelicerae and book gills of Chelicerata

Nature Yu Liu, Lorenzo Lustri, Huijuan Mai et al. Jul 01, 2026 DOI: 10.1038/s41586-026-10713-2

Quantum‐Corrected Plasmonic Effect of Au <sub>25</sub> Clusters Regulates Adsorption Behaviors for Boosted Photocatalytic Overall Water Splitting

Advanced Materials Shaohui Guo, Jing Wen, Wei Zhao et al. Jul 01, 2026 DOI: 10.1002/adma.73778

ABSTRACT Plasmonic‐assisted solar‐driven photocatalytic water splitting for hydrogen production represents a sustainable strategy for green energy generation. However, conventional plasmonic enhancement via photo‐induced electron injection into water molecules faces a key limitation: weak interfacial H 2 O adsorption characterized by restriction solely to H‐atom‐mediated interactions, which severely constrains reaction kinetics. Simultaneously, the novel quantum‐corrected plasmonic effect could improve the electron models in optoelectronic device; however, within the domain of photocatalytic water splitting, experimental validations of this effect remain relatively scarce. Here, we harness the quantum‐corrected plasmonic effect via Au 25 nanocluster incorporation to realize and enhance photocatalytic overall water splitting performance, facilitated by modulated surface adsorption behavior through electron‐deficient Au δ+ active sites originating from the size effect and interband transitions. In this case, the Au δ+ active sites enhance the antibonding‐orbital occupancy of adsorbed Au‐O species, accelerating both multipath electron injection and the activation process of water molecules, ultimately facilitating the cleavage of H─O bonds. Consequently, it achieves H 2 and O 2 evolution rates of 1.07 and 0.54 mmol h −1 under light irradiation with catalyst ZnIn 2 S 4 ‐Au 25 , resolving the long‐standing challenge of incomplete overall water splitting for sole Au nanoparticle‐decorated photocatalysts, providing a promising strategy for photocatalytic overall water splitting and new insights into designing nanocluster‐based photocatalysts.

Interface and Surface Chemistry Engineering in HgTe Quantum Dots for High‐Performance Infrared Optoelectronic Devices

Advanced Materials Muhammad Sulaman, Tao Zhao, Ali Usman et al. Jul 01, 2026 DOI: 10.1002/adma.73486

ABSTRACT Colloidal quantum dots composed of mercury telluride (HgTe) have emerged as promising materials for infrared detection systems, imaging applications, focal plane array technologies, and various other optoelectronic platforms. These nanomaterials exhibit a distinctive bandgap that can be controlled through particle size manipulation, covering wavelengths from the near‐infrared through terahertz regions, and demonstrate robust charge carrier transport characteristics that position them favorably for advanced infrared technological applications. This review consolidates current developments in HgTe CQD fabrication methods, their electronic band structures, and integration strategies for functional devices. The nanoscale dimensions of HgTe induce quantum confinement phenomena that enable precise bandgap engineering, transitioning from negative to positive energy gaps and facilitating tunable light absorption and emission across an extensive wavelength spectrum. We analyze how variations in nanoparticle dimensions, morphology, and surface functionalization impact their optical behavior and electrical transport characteristics. Additionally, we explore the implementation of HgTe CQDs in photodetection platforms, field‐effect transistor configurations, and imaging array architectures, emphasizing design strategies, operational characteristics, and durability limitations. This comprehensive survey seeks to advance understanding of HgTe CQD systems and facilitate their continued evolution toward commercially viable, cost‐effective, and high‐efficiency infrared optoelectronic solutions.

The cannabinoid receptor 1 suppresses neuropeptide Y transcription in the peripheral nervous system to mediate analgesia

Journal of Biological Chemistry YongMin Liu, Xue Gong, Yindi Wang et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113350

Association of tumor microenvironment landscape with neoadjuvant therapy resistance in hormone receptor–positive breast cancer.

Journal of Clinical Oncology Zhen Wang, Chenghui Yang, Tianyi Qian et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.37

37 Background: Hormone receptor (HR)–positive breast cancer shows limited sensitivity to neoadjuvant therapy, with pCR rates below 10%—significantly lower than the rates in HER2-positive and triple-negative breast cancer. We investigated the immune characteristics of the tumor microenvironment associated with different pCR outcomes in HR-positive breast cancer. Methods: Pretreatment core biopsy samples were obtained from 36 patients with HR-positive breast cancer who received eight cycles of neoadjuvant EC–T chemotherapy and were stratified based on postoperative pCR status. Single-cell RNA sequencing was performed on samples from 8 patients, while imaging mass cytometry (IMC) was conducted on samples from 28 patients to characterize the spatial immune landscape. In addition, functional assays were performed to further investigate cellular interactions within the tumor immune microenvironment. Results: All patients had clinical stage II–III, HER2-negative, ER/PR-positive breast cancer. Imaging mass cytometry identified 24 distinct cellular clusters and 10 tumor communities within the HR-positive tumor microenvironment. Integrated single-cell RNA sequencing and IMC analyses defined five tumor cell subpopulations. A tumor community dominated by E-cadherin–low tumor cells was significantly enriched in the non-pCR group and was characterized by surrounding fibroblasts that spatially separated tumor cells from immune infiltration. Multicolor immunofluorescence further demonstrated a significant positive correlation between tumor E-cadherin expression and pCR rates following neoadjuvant therapy in HR-positive breast cancer. Mechanistically, E-cadherin–low tumor cells exhibited increased secretion of NAMPT, which interacted specifically with fibroblasts, promoted collagen barrier formation, and contributed to an immune-desert tumor microenvironment. Conclusions: Single-cell and spatial analyses reveal tumor microenvironment–driven mechanisms of neoadjuvant therapy resistance in HR-positive breast cancer, providing a basis for early response prediction and precision therapy. Research Sponsor: "Pioneer" and "Leading Goose" R&amp;D Program of Zhejiang (2026C02A1111); National Natural Science Foundation of China (82273449).

Comparative effectiveness of first-line pembrolizumab plus chemotherapy, nivolumab plus chemotherapy, and nivolumab plus ipilimumab in metastatic esophageal squamous cell carcinoma: A propensity score-matched real-world analysis.

Journal of Clinical Oncology Shankar Biswas, Yashasvi Srivastava, Rahul Falodia et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.135

135 Background: Pembrolizumab plus chemotherapy (KEYNOTE-590), nivolumab plus chemotherapy, and nivolumab plus ipilimumab (CheckMate 648) are approved first-line regimens for advanced esophageal squamous cell carcinoma (ESCC). No head-to-head trial or real-world study has directly compared them. We performed pairwise propensity score-matched (PSM) comparisons using a global federated electronic health record network. Methods: Adults with metastatic ESCC (ICD-10 C15 + C78/C79) receiving pembrolizumab+chemotherapy (A), nivolumab+chemotherapy (B), or nivolumab+ipilimumab (C) were identified from the TriNetX Global Collaborative Network (171 organizations). 1:1 nearest-neighbor PSM balanced demographics, Charlson comorbidities, and baseline labs. Outcomes included overall survival (OS) and safety events. Hazard ratios (HR) with 95% CI were estimated via Kaplan-Meier with log-rank testing. Results: Pre-match cohorts comprised 813 (A), 1424 (B), and 253 (C) patients. After PSM, balanced pairs were obtained for all comparisons (Table). OS was comparable between A and B (median 381 vs 360 days; HR 1.11; p=0.162). C showed significantly better OS than B (median 443 vs 303 days; HR 1.38; p=0.029) and trended toward better OS than A (median 411 vs 292 days; HR 0.76; p=0.069). Neutropenia was significantly higher with both chemo-containing regimens versus C (p≤0.011). No differences in colitis, hypothyroidism, or nausea/vomiting were observed. Conclusions: In this real-world PSM analysis, pembrolizumab+chemotherapy and nivolumab+chemotherapy showed comparable OS in first-line metastatic ESCC. Nivolumab+ipilimumab was associated with longer OS versus nivolumab+chemotherapy and markedly lower neutropenia versus both chemo-containing regimens, supporting the chemo-free regimen as a viable option particularly for patients at risk for hematologic toxicity. Comparison (C1 vs C2) N/arm mOS C1 (d) mOS C2 (d) HR (95% CI) p Neutropenia C1 vs C2 A vs B 678 381 360 1.11 (0.96–1.27) 0.162 16.7% vs 24.3% (p=0.003) A vs C 162 292 411 0.76 (0.57–1.02) 0.069 18.7% vs 7.7% (p=0.011) B vs C 166 303 443 1.38 (1.03–1.84) 0.029 28.4% vs 8.3% (p&lt;0.001) A=pembrolizumab+chemo; B=nivolumab+chemo; C=nivolumab+ipilimumab; d=days; mOS=median overall survival.

Absolute chronology of the Early Palaeolithic Karatau Culture in Central Asia

Nature Communications Aske L. Sørensen, Anton A. Anoikin, Kseniya A. Kolobova et al. Jul 01, 2026 DOI: 10.1038/s41467-026-74938-5

Abstract Central Asia represents a key region for our understanding of early human dispersal patterns, because it served as a migration corridor that linked the Levant and southern Caucasus with Northeast Asia. However, no Early Palaeolithic sites in Central Asia are anchored with reliable age constraints, including the thick loess-palaeosol sections in Tajikistan that recorded early human activities and environmental changes over multiple glacial-interglacial cycles. This lack of absolute age constraints is presently a key factor limiting our understanding of the early human occupation history of this region. Here, we provide a comprehensive description and an absolute chronological framework for the Early Palaeolithic Karatau Culture; defined by the rich lithic assemblages found in palaeosols in the Khovaling Loess Plateau, Tajikistan. Age constraints are provided through multi-method analysis of three loess-palaeosol sections in the Khovaling Loess Plateau, combining luminescence ages, cosmogenic 26 Al- 10 Be concentrations, and magnetostratigraphic boundaries into a probabilistic inverse age-depth model. This model shows that the Karatau Culture flourished with the onset of Marine Isotope Stage 15, thrived during Marine Isotope Stage 13 and 11, but disappeared around onset of Marine Isotope Stage 10. We frame the archaeological occupations within local and regional ecological settings to better understand the drivers of Pleistocene human migrations in Central Asia.

Top-down and bottom-up attention for joint pattern classification and reconstruction

PLoS ONE Ricardo A. Veiga, Bonifacio Silvano Zanutto Jul 01, 2026 DOI: 10.1371/journal.pone.0351985

We introduce a recurrent inference framework for the Classification and Reconstruction of Overlapping Patterns (CROP) in mixtures formed by overlapping two patterns drawn from the same distribution. The framework alternates between bottom-up classification and top-down generative reconstruction within an iterative inference procedure. At each iteration, the method estimates the most likely class present in the mixture, reconstructs the corresponding signal using a conditional generative model, and applies a mask to isolate that component. This classification-guided reconstruction progressively separates the overlapping signals while also producing their class labels. The objective is therefore to iteratively separate and classify the overlapping patterns rather than perform general blind source separation. An important feature of the framework is that the generative model can be trained using only clean samples, without requiring paired mixed–clean training data. The iterative procedure implicitly implements a form of attention in which saliency- and priority-driven estimates guide the masking and reconstruction of individual patterns. Experimental results on mixtures of handwritten digits show that the proposed framework can successfully separate and classify overlapping patterns through this iterative classification–reconstruction process.

Development of a hemolysis filter system for the selective removal of free hemoglobin, haem and iron from blood envisaged for use in extracorporeal circuits

Scientific Reports Noora Naghavi, Lisa Barbaro, Mark JD. Griffiths et al. Jul 01, 2026 DOI: 10.1038/s41598-026-57088-y

Abstract Hemolysis, the rupture of red blood cells, releases hemoglobin, haem, and redox-active iron into the bloodstream. When the body’s scavenging capacity is overwhelmed, these species can exert deleterious effects, as seen in hemolytic disorders. Hemolysis can also occur in extracorporeal circuits due to mechanical forces acting on blood during circulation. To mitigate these effects, we developed a filter designed for integration into extracorporeal circuits that is designed to capture hemolysis-associated byproducts using immobilised ligands. The filter prototype comprises glyoxal-functionalized agarose beads covalently immobilized with three binding agents: haptoglobin (Hp, binds cell-free hemoglobin [cfHb]), human serum albumin (HSA, binds haem), and desferrioxamine (DFO, binds free iron). Ligand immobilization was optimized to achieve strong covalent attachment to the agarose matrix. Optimized immobilization produced high ligand loading per milliliter of beads (mean ± SD): Hp 74.4 ± 11.7 mg/mL, HSA 84.6 ± 8.2 mg/mL, and DFO 43.3 ± 4.8 mg/mL. In vitro studies showed removal capacities of 12.7 ± 0.2 mg/mL for cfHb, 2708.5 ± 18.5 µg/mL for haem, and 309.7 ± 13.7 µg/mL for iron. The system retained binding activity in plasma and hemolyzed whole blood, and no increase in TAT or D-dimer was detected under the tested ex vivo conditions. These findings demonstrate the potential of this affinity-based filtration system to reduce hemolysis-associated complications in extracorporeal circulation.

The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK–p65 NF-κB signaling and inflammatory cytokine production to suppress triple-negative breast cancer progression

Journal of Biological Chemistry Julio M. Pimentel, Oye Bosompra, JoAnn Trejo Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113341